CIK 0000059478
- Large accelerated filer
ELI LILLY & Co
Sign in to watch- Ticker
- LLY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- Operating
- EIN
- 350470950
- Phone
- +1 317-276-2000
- Business address
- LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285
- Former names
- LILLY ELI & CO, LILLY ELI & CO ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,012,600
- in 1 filing, $7.0M under 10b5-1 plans
Net −$7,012,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-15 | Sulzberger Gabrielle Director | Grant or award | +6.63 | $748.19 | $5K | 2,721.97 |
| 2025-09-15 | LUCIANO JUAN R Director | Grant or award | +19.83 | $748.19 | $15K | 16,455.86 |
| 2025-09-15 | Fyrwald J Erik Director | Grant or award | +13.25 | $748.19 | $10K | 74,751.39 |
| 2025-09-05 | Hernandez Edgardo EVP & Pres., Mfg. Operations | Gift | −17 | 39,731.44 | ||
| 2025-08-28 | Zakrowski Donald A SVP, Finance, & CAO | Sale 10b5-1 | −1,000 | $734.93 | $735K | 3,839.66 |
| 2025-08-27 | Custer Kenneth L. EVP & President, Card Met Hlth | Other acquisition · Phantom Stock | +612.94 | $734.17 | $450K | 2,173.46 |
| 2025-08-18 | Sulzberger Gabrielle Director | Grant or award | +7.1 | $698.05 | $5K | 2,710.16 |
| 2025-08-18 | LUCIANO JUAN R Director | Grant or award | +21.25 | $698.05 | $15K | 16,403.18 |
| 2025-08-18 | Hedley Mary Lynne Director | Grant or award | +14.21 | $698.05 | $10K | 1,986.78 |
| 2025-08-18 | Fyrwald J Erik Director | Grant or award | +14.21 | $698.05 | $10K | 74,591.99 |
| 2025-08-18 | Alvarez Ralph Director | Grant or award | +16.83 | $698.05 | $12K | 55,011.41 |
| 2025-08-15 | Montarce Lucas EVP & CFO | Purchase | +715 | $691.79 | $495K | 14,684.74 |
| 2025-08-13 | Alvarez Ralph Director | Purchase | +758 | $660.25 | $500K | 758 |
| 2025-08-13 | Van Naarden Jacob EVP & Pres., Lilly Oncology | Purchase | +1,000 | $647.36 | $647K | 20,561.99 |
| 2025-08-12 | Ricks David A President, Chair, and CEO | Purchase | +1,632 | $644.77 | $1.1M | 546,601.17 |
| 2025-08-12 | Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm | Purchase | +1,000 | $634.41 | $634K | 137,660.11 |
| 2025-08-12 | Sulzberger Gabrielle Director | Purchase | +117 | $641.18 | $75K | 2,703.06 |
| 2025-08-12 | Fyrwald J Erik Director | Purchase | +686 | $642.00 | $440K | 73,698.78 |
| 2025-08-12 | Fyrwald J Erik Director | Purchase | +879 | $642.59 | $565K | 74,577.78 |
| 2025-08-11 | Yuffa Ilya EVP&Pres, LLY USA&Global Capab | Sale 10b5-1 | −1,250 | $627.01 | $784K | 26,259.97 |
Page 28 of 32 · 630 trades